Cancer Supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects.

The global Cancer Supportive Care Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cancer Supportive Care Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Supportive Care Drugs.

Report Scope

The Cancer Supportive Care Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Supportive Care Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Supportive Care Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Supportive Care Drugs Market Report

Report Metric	Details
Report Name	Cancer Supportive Care Drugs Market
CAGR	5%
Segment by Type	Granulocyte-Colony Stimulating Factors (G-CSFS) Erythropoietin-Stimulating Agents (ESAS) Antiemetics Bisphosphonates Opioids Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) Others
Segment by Application	Breast Cancer Lung Cancer Melanoma Prostate Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Johnson & Johnson, Novartis, Baxter International, Fagron Group, Teva Pharmaceuticals Industries, F.Hoffmann La-Roche Ltd, Apr Applied Pharma Science Research, Acacia Pharma, Kyowa Hakko Kirin, Helsinn Healthcare, Heron Pharma, Merck & Co. Inc, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Supportive Care Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Supportive Care Drugs Market report?

Ans: The main players in the Cancer Supportive Care Drugs Market are Amgen, Johnson & Johnson, Novartis, Baxter International, Fagron Group, Teva Pharmaceuticals Industries, F.Hoffmann La-Roche Ltd, Apr Applied Pharma Science Research, Acacia Pharma, Kyowa Hakko Kirin, Helsinn Healthcare, Heron Pharma, Merck & Co. Inc, Sanofi

What are the Application segmentation covered in the Cancer Supportive Care Drugs Market report?

Ans: The Applications covered in the Cancer Supportive Care Drugs Market report are Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer, Others

What are the Type segmentation covered in the Cancer Supportive Care Drugs Market report?

Ans: The Types covered in the Cancer Supportive Care Drugs Market report are Granulocyte-Colony Stimulating Factors (G-CSFS), Erythropoietin-Stimulating Agents (ESAS), Antiemetics, Bisphosphonates, Opioids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Supportive Care Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Granulocyte-Colony Stimulating Factors (G-CSFS)

1.2.3 Erythropoietin-Stimulating Agents (ESAS)

1.2.4 Antiemetics

1.2.5 Bisphosphonates

1.2.6 Opioids

1.2.7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

1.2.8 Others

1.3 Market by Application

1.3.1 Global Cancer Supportive Care Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Melanoma

1.3.5 Prostate Cancer

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Supportive Care Drugs Market Perspective (2019-2030)

2.2 Cancer Supportive Care Drugs Growth Trends by Region

2.2.1 Global Cancer Supportive Care Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Supportive Care Drugs Historic Market Size by Region (2019-2024)

2.2.3 Cancer Supportive Care Drugs Forecasted Market Size by Region (2025-2030)

2.3 Cancer Supportive Care Drugs Market Dynamics

2.3.1 Cancer Supportive Care Drugs Industry Trends

2.3.2 Cancer Supportive Care Drugs Market Drivers

2.3.3 Cancer Supportive Care Drugs Market Challenges

2.3.4 Cancer Supportive Care Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Supportive Care Drugs Players by Revenue

3.1.1 Global Top Cancer Supportive Care Drugs Players by Revenue (2019-2024)

3.1.2 Global Cancer Supportive Care Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Supportive Care Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Supportive Care Drugs Revenue

3.4 Global Cancer Supportive Care Drugs Market Concentration Ratio

3.4.1 Global Cancer Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Supportive Care Drugs Revenue in 2023

3.5 Cancer Supportive Care Drugs Key Players Head office and Area Served

3.6 Key Players Cancer Supportive Care Drugs Product Solution and Service

3.7 Date of Enter into Cancer Supportive Care Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Supportive Care Drugs Breakdown Data by Type

4.1 Global Cancer Supportive Care Drugs Historic Market Size by Type (2019-2024)

4.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2025-2030)

5 Cancer Supportive Care Drugs Breakdown Data by Application

5.1 Global Cancer Supportive Care Drugs Historic Market Size by Application (2019-2024)

5.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Supportive Care Drugs Market Size (2019-2030)

6.2 North America Cancer Supportive Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cancer Supportive Care Drugs Market Size by Country (2019-2024)

6.4 North America Cancer Supportive Care Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Supportive Care Drugs Market Size (2019-2030)

7.2 Europe Cancer Supportive Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cancer Supportive Care Drugs Market Size by Country (2019-2024)

7.4 Europe Cancer Supportive Care Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Supportive Care Drugs Market Size (2019-2030)

8.2 Asia-Pacific Cancer Supportive Care Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Supportive Care Drugs Market Size (2019-2030)

9.2 Latin America Cancer Supportive Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cancer Supportive Care Drugs Market Size by Country (2019-2024)

9.4 Latin America Cancer Supportive Care Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Supportive Care Drugs Market Size (2019-2030)

10.2 Middle East & Africa Cancer Supportive Care Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Detail

11.1.2 Amgen Business Overview

11.1.3 Amgen Cancer Supportive Care Drugs Introduction

11.1.4 Amgen Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.1.5 Amgen Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Cancer Supportive Care Drugs Introduction

11.2.4 Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Cancer Supportive Care Drugs Introduction

11.3.4 Novartis Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Baxter International

11.4.1 Baxter International Company Detail

11.4.2 Baxter International Business Overview

11.4.3 Baxter International Cancer Supportive Care Drugs Introduction

11.4.4 Baxter International Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.4.5 Baxter International Recent Development

11.5 Fagron Group

11.5.1 Fagron Group Company Detail

11.5.2 Fagron Group Business Overview

11.5.3 Fagron Group Cancer Supportive Care Drugs Introduction

11.5.4 Fagron Group Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.5.5 Fagron Group Recent Development

11.6 Teva Pharmaceuticals Industries

11.6.1 Teva Pharmaceuticals Industries Company Detail

11.6.2 Teva Pharmaceuticals Industries Business Overview

11.6.3 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Introduction

11.6.4 Teva Pharmaceuticals Industries Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.6.5 Teva Pharmaceuticals Industries Recent Development

11.7 F.Hoffmann La-Roche Ltd

11.7.1 F.Hoffmann La-Roche Ltd Company Detail

11.7.2 F.Hoffmann La-Roche Ltd Business Overview

11.7.3 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Introduction

11.7.4 F.Hoffmann La-Roche Ltd Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.7.5 F.Hoffmann La-Roche Ltd Recent Development

11.8 Apr Applied Pharma Science Research

11.8.1 Apr Applied Pharma Science Research Company Detail

11.8.2 Apr Applied Pharma Science Research Business Overview

11.8.3 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Introduction

11.8.4 Apr Applied Pharma Science Research Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.8.5 Apr Applied Pharma Science Research Recent Development

11.9 Acacia Pharma

11.9.1 Acacia Pharma Company Detail

11.9.2 Acacia Pharma Business Overview

11.9.3 Acacia Pharma Cancer Supportive Care Drugs Introduction

11.9.4 Acacia Pharma Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.9.5 Acacia Pharma Recent Development

11.10 Kyowa Hakko Kirin

11.10.1 Kyowa Hakko Kirin Company Detail

11.10.2 Kyowa Hakko Kirin Business Overview

11.10.3 Kyowa Hakko Kirin Cancer Supportive Care Drugs Introduction

11.10.4 Kyowa Hakko Kirin Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.10.5 Kyowa Hakko Kirin Recent Development

11.11 Helsinn Healthcare

11.11.1 Helsinn Healthcare Company Detail

11.11.2 Helsinn Healthcare Business Overview

11.11.3 Helsinn Healthcare Cancer Supportive Care Drugs Introduction

11.11.4 Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.11.5 Helsinn Healthcare Recent Development

11.12 Heron Pharma

11.12.1 Heron Pharma Company Detail

11.12.2 Heron Pharma Business Overview

11.12.3 Heron Pharma Cancer Supportive Care Drugs Introduction

11.12.4 Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.12.5 Heron Pharma Recent Development

11.13 Merck & Co. Inc

11.13.1 Merck & Co. Inc Company Detail

11.13.2 Merck & Co. Inc Business Overview

11.13.3 Merck & Co. Inc Cancer Supportive Care Drugs Introduction

11.13.4 Merck & Co. Inc Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.13.5 Merck & Co. Inc Recent Development

11.14 Sanofi

11.14.1 Sanofi Company Detail

11.14.2 Sanofi Business Overview

11.14.3 Sanofi Cancer Supportive Care Drugs Introduction

11.14.4 Sanofi Revenue in Cancer Supportive Care Drugs Business (2019-2024)

11.14.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Teva Pharmaceuticals Industries

F Hoffmann La Roche Ltd

APR Applied Pharma Science Research

List of Tables

Table 1. Global Cancer Supportive Care Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Granulocyte-Colony Stimulating Factors (G-CSFS)

Table 3. Key Players of Erythropoietin-Stimulating Agents (ESAS)

Table 4. Key Players of Antiemetics

Table 5. Key Players of Bisphosphonates

Table 6. Key Players of Opioids

Table 7. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

Table 8. Key Players of Others

Table 9. Global Cancer Supportive Care Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Cancer Supportive Care Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Cancer Supportive Care Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 12. Global Cancer Supportive Care Drugs Market Share by Region (2019-2024)

Table 13. Global Cancer Supportive Care Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 14. Global Cancer Supportive Care Drugs Market Share by Region (2025-2030)

Table 15. Cancer Supportive Care Drugs Market Trends

Table 16. Cancer Supportive Care Drugs Market Drivers

Table 17. Cancer Supportive Care Drugs Market Challenges

Table 18. Cancer Supportive Care Drugs Market Restraints

Table 19. Global Cancer Supportive Care Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 20. Global Cancer Supportive Care Drugs Market Share by Players (2019-2024)

Table 21. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Supportive Care Drugs as of 2023)

Table 22. Ranking of Global Top Cancer Supportive Care Drugs Companies by Revenue (US$ Million) in 2023

Table 23. Global 5 Largest Players Market Share by Cancer Supportive Care Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 24. Key Players Headquarters and Area Served

Table 25. Key Players Cancer Supportive Care Drugs Product Solution and Service

Table 26. Date of Enter into Cancer Supportive Care Drugs Market

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Cancer Supportive Care Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 29. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2019-2024)

Table 30. Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 31. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2025-2030)

Table 32. Global Cancer Supportive Care Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 33. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2019-2024)

Table 34. Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 35. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2025-2030)

Table 36. North America Cancer Supportive Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Cancer Supportive Care Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Cancer Supportive Care Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Cancer Supportive Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Europe Cancer Supportive Care Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 41. Europe Cancer Supportive Care Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 42. Asia-Pacific Cancer Supportive Care Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 43. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 44. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 45. Latin America Cancer Supportive Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Latin America Cancer Supportive Care Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 47. Latin America Cancer Supportive Care Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 48. Middle East & Africa Cancer Supportive Care Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 50. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 51. Amgen Company Detail

Table 52. Amgen Business Overview

Table 53. Amgen Cancer Supportive Care Drugs Product

Table 54. Amgen Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. Johnson & Johnson Company Detail

Table 57. Johnson & Johnson Business Overview

Table 58. Johnson & Johnson Cancer Supportive Care Drugs Product

Table 59. Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 60. Johnson & Johnson Recent Development

Table 61. Novartis Company Detail

Table 62. Novartis Business Overview

Table 63. Novartis Cancer Supportive Care Drugs Product

Table 64. Novartis Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 65. Novartis Recent Development

Table 66. Baxter International Company Detail

Table 67. Baxter International Business Overview

Table 68. Baxter International Cancer Supportive Care Drugs Product

Table 69. Baxter International Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 70. Baxter International Recent Development

Table 71. Fagron Group Company Detail

Table 72. Fagron Group Business Overview

Table 73. Fagron Group Cancer Supportive Care Drugs Product

Table 74. Fagron Group Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 75. Fagron Group Recent Development

Table 76. Teva Pharmaceuticals Industries Company Detail

Table 77. Teva Pharmaceuticals Industries Business Overview

Table 78. Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Product

Table 79. Teva Pharmaceuticals Industries Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 80. Teva Pharmaceuticals Industries Recent Development

Table 81. F.Hoffmann La-Roche Ltd Company Detail

Table 82. F.Hoffmann La-Roche Ltd Business Overview

Table 83. F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Product

Table 84. F.Hoffmann La-Roche Ltd Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 85. F.Hoffmann La-Roche Ltd Recent Development

Table 86. Apr Applied Pharma Science Research Company Detail

Table 87. Apr Applied Pharma Science Research Business Overview

Table 88. Apr Applied Pharma Science Research Cancer Supportive Care Drugs Product

Table 89. Apr Applied Pharma Science Research Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 90. Apr Applied Pharma Science Research Recent Development

Table 91. Acacia Pharma Company Detail

Table 92. Acacia Pharma Business Overview

Table 93. Acacia Pharma Cancer Supportive Care Drugs Product

Table 94. Acacia Pharma Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 95. Acacia Pharma Recent Development

Table 96. Kyowa Hakko Kirin Company Detail

Table 97. Kyowa Hakko Kirin Business Overview

Table 98. Kyowa Hakko Kirin Cancer Supportive Care Drugs Product

Table 99. Kyowa Hakko Kirin Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 100. Kyowa Hakko Kirin Recent Development

Table 101. Helsinn Healthcare Company Detail

Table 102. Helsinn Healthcare Business Overview

Table 103. Helsinn Healthcare Cancer Supportive Care Drugs Product

Table 104. Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 105. Helsinn Healthcare Recent Development

Table 106. Heron Pharma Company Detail

Table 107. Heron Pharma Business Overview

Table 108. Heron Pharma Cancer Supportive Care Drugs Product

Table 109. Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 110. Heron Pharma Recent Development

Table 111. Merck & Co. Inc Company Detail

Table 112. Merck & Co. Inc Business Overview

Table 113. Merck & Co. Inc Cancer Supportive Care Drugs Product

Table 114. Merck & Co. Inc Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 115. Merck & Co. Inc Recent Development

Table 116. Sanofi Company Detail

Table 117. Sanofi Business Overview

Table 118. Sanofi Cancer Supportive Care Drugs Product

Table 119. Sanofi Revenue in Cancer Supportive Care Drugs Business (2019-2024) & (US$ Million)

Table 120. Sanofi Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Supportive Care Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cancer Supportive Care Drugs Market Share by Type: 2023 VS 2030

Figure 3. Granulocyte-Colony Stimulating Factors (G-CSFS) Features

Figure 4. Erythropoietin-Stimulating Agents (ESAS) Features

Figure 5. Antiemetics Features

Figure 6. Bisphosphonates Features

Figure 7. Opioids Features

Figure 8. Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) Features

Figure 9. Others Features

Figure 10. Global Cancer Supportive Care Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Cancer Supportive Care Drugs Market Share by Application: 2023 VS 2030

Figure 12. Breast Cancer Case Studies

Figure 13. Lung Cancer Case Studies

Figure 14. Melanoma Case Studies

Figure 15. Prostate Cancer Case Studies

Figure 16. Others Case Studies

Figure 17. Cancer Supportive Care Drugs Report Years Considered

Figure 18. Global Cancer Supportive Care Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Cancer Supportive Care Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Cancer Supportive Care Drugs Market Share by Region: 2023 VS 2030

Figure 21. Global Cancer Supportive Care Drugs Market Share by Players in 2023

Figure 22. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Supportive Care Drugs as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Cancer Supportive Care Drugs Revenue in 2023

Figure 24. North America Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Cancer Supportive Care Drugs Market Share by Country (2019-2030)

Figure 26. United States Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Cancer Supportive Care Drugs Market Share by Country (2019-2030)

Figure 30. Germany Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Cancer Supportive Care Drugs Market Share by Region (2019-2030)

Figure 38. China Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Cancer Supportive Care Drugs Market Share by Country (2019-2030)

Figure 46. Mexico Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Cancer Supportive Care Drugs Market Share by Country (2019-2030)

Figure 50. Turkey Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Cancer Supportive Care Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Amgen Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 53. Johnson & Johnson Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 55. Baxter International Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 56. Fagron Group Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 57. Teva Pharmaceuticals Industries Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 58. F.Hoffmann La-Roche Ltd Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 59. Apr Applied Pharma Science Research Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 60. Acacia Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 61. Kyowa Hakko Kirin Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 62. Helsinn Healthcare Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 63. Heron Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 64. Merck & Co. Inc Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 65. Sanofi Revenue Growth Rate in Cancer Supportive Care Drugs Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions